Microbiome Labs is excited to announce the publication of their most recent study, “Bacillus spp. Spores—A Promising Treatment Option for Patients with Irritable Bowel Syndrome.” This prospective, randomized clinical study took place at a medical center in Romania and included 90 patients with irritable bowel syndrome (IBS).
IBS severity scores examined the severity of abdominal pain and the number of days with pain or distention, as well as the impact of each on quality of life. Quality of life evaluated functional status (physical and social functioning and physical and emotional problems), well-being (mental health, vitality, and pain), and general health assessment (general perception of health). Rectal volume sensation tests are conducted with expanding balloon catheters to measure sensory thresholds, which, when elevated, are characteristic of constipation and fecal incontinence.